3-Ethynylaniline CAS 54060-30-9 Kemurnian >99,0% (GC) Erlotinib Hydrochloride Intermediate

Katrangan singkat:

Jeneng Kimia: 3-Ethynylaniline

Sinonim: 3-Aminophenylacetylene

CAS: 54060-30-9

Kemurnian:> 99,0% (GC)

Penampilan: Cairan Cairan Kuning nganti Coklat

Intermediate Erlotinib Hydrochloride (CAS: 183319-69-9)

Kontak: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Produsen utama lan pemasok Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-siji CAS 179688-29-0
Please contact: alvin@ruifuchem.com

Sifat Kimia:

Jeneng Kimia	3-Ethynylaniline
sinonim	3-Aminophenylacetylene
Nomer CAS	54060-30-9
Nomer CAT	RF-PI2241
Status Simpenan	Ing Simpenan, Kapasitas Produksi 50MT / Wulan
Formula Molekul	C8H7N
Bobot Molekul	117.15
Sensitif	Sensitif Udara, Sensitif Cahya
Titik didih	120 ℃ / 20 mmHg
Kelarutan banyu	Ora larut ing banyu
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Cairan Cairan Kuning nganti Coklat
Kemurnian / Metode Analisis	> 99,0% (GC)
Banyu dening Karl Fischer	<0,50%
Sisa ing Ignition	<0,20%
Total Impurities	<1.00%
Gravitasi spesifik (20/20 ℃)	1.041~1.048
Indeks bias n20/D	1.614~1.6195
Spektrum Infrared	Conforms kanggo Struktur
Proton NMR Spectrum	Conforms kanggo Struktur
Test Standar	Standar Perusahaan
Panggunaan	Pharmaceutical Intermediate;Erlotinib Hydrochloride Intermediate

Paket & Panyimpenan:

Paket: Botol Fluorinated, 25kg / Drum, utawa miturut kabutuhan pelanggan

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan

Kaluwihan:

FAQ:

Aplikasi:

3-Ethynylaniline, uga dikenal minangka 3-Aminophenylacetylene (CAS: 54060-30-9) digunakake minangka penengah pharmaceutical.3-Ethynylaniline minangka perantara saka Erlotinib Hydrochloride (CAS: 183319-69-9).Erlotinib Hydrochloride minangka inhibitor tirosin kinase molekul cilik sing tumindak kanthi reversibel ing reseptor pertumbuhan epidermis, hidroklorida saka erlotinib, obat sing ditargetake molekuler.US Food and Drug Administration (FDA) wis nyetujoni erlotinib (Tarceva) digabungake karo gemcitabine minangka perawatan lini pertama kanggo kanker pankreas sing maju lan metastatik lokal.Utamane digunakake minangka perawatan baris kapindho utawa katelu kanggo kanker paru-paru sel non-cilik (NSCLC) maju utawa metstatic lokal lan minangka perawatan kanggo kanker pankreas.Iki digunakake minangka inhibitor tirosin kanggo perawatan NSCLC.Erlotinib Hydrochloride, quinazoline asalé saka inhibitor molekul cilik saka epidermal growth receptor (EDGFR) tyrosine kinase, disetujoni ing November, 2004, kanggo perawatan kanker paru-paru non-sel cilik metastatik lanjut utawa metastatik.